Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platformᅢᄁ¬ダᅡᄁ, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.